Bioxcel Therapeutics deal with Teva includes $57.5M cash
Bioxcel Therapeutics said its deal with Teva includes $57.5 million cash and up to $67.5 million in development milestones.
Story updates
10:18:34 AM UTC
SquawkNews
Teva Pharmaceuticals: Deal Part of Court-Supervised Sale Process With BioXcel Therapeutics
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.